Affiliation:
1. Immune Deficiency Diseases Research Group, Clinical Research Centre, Harrow, England
Abstract
SUMMARY
We have assessed the ability of interleukin-2 (IL-2) and interleukin-6 (IL-6) to augment the proliferative response of T lymphocytes from ‘common-variable’ hypogammaglobulinaemia (CVH) patients and from normal controls, to the mitogens phytohaemagglutinin (PHA) and OKT3. We show that with cells from the control group and from those patients whose T cells respond to PHA within the control range, both IL-2 and IL-6 will significantly augment the response to OKT3. However, in those patients with a T cell defect in which the PHA response is below the control range, neither IL-2 nor IL-6 could restore the PHA or OKT3 response to normal. Responses to IL-2 or IL-6 alone were always in or above the control range.
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference23 articles.
1. Concomitant production of different lymphokines in activated T cells;Andersson;Eur. J. Immunol.,1988
2. The interleukin 2 Tcell system: a new cell growth model;Cantrell;Science,1984
3. Auto-crine regulation of T lymphocyte proliferation: differential induction of IL-2 and IL-2 receptor;Cantrell;Immunology,1988
4. Human T cell activation with phytohemagglutinin: the function of IL-6 as an accessory signal;Ceuppens;J. Immunol.,1988
5. Requirement for mitogen, T cell-accessory cell contact, and inter-leukin 1 in induction of resting T-cell proliferation;Chatila;Clin. Immunol. Immunopathol.,1987
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献